These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9477116)

  • 1. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections.
    Sheridan J; Kern E; Martin A; Booth A
    Antiviral Res; 1997 Dec; 36(3):157-66. PubMed ID: 9477116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
    Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
    Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir treatment of experimental genital herpes simplex virus infections.
    Kern ER
    Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.
    Miller RL; Imbertson LM; Reiter MJ; Gerster JF
    Antiviral Res; 1999 Nov; 44(1):31-42. PubMed ID: 10588331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
    Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
    J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.
    Bravo FJ; Stanberry LR; Kier AB; Vogt PE; Kern ER
    Antiviral Res; 1993 May; 21(1):59-72. PubMed ID: 8391249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.
    Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
    J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.
    Jennings R; Smith TL; Myhren F; Phillips J; Sandvold ML
    Antimicrob Agents Chemother; 1999 Jan; 43(1):53-61. PubMed ID: 9869565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.
    Bernstein DI; Bravo FJ; Pullum DA; Shen H; Wang M; Rahman A; Glazer RI; Cardin RD
    Antivir Chem Chemother; 2015 Feb; 24(1):19-27. PubMed ID: 26149263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the dorsal cutaneous guinea pig model in selecting topical antiviral formulations for the treatment of recurrent herpes simplex type 1 disease.
    Poli G; Dall'Ara P; Binda S; Santus G; Poli A; Cocilovo A; Ponti W
    Arzneimittelforschung; 2001; 51(5):433-8. PubMed ID: 11413746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
    Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
    Park NH; Pavan-Langston D; McLean SL; Lass JH
    Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
    Quenelle DC; Collins DJ; Marciani DJ; Kern ER
    Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1983 Nov; 3(4):253-67. PubMed ID: 6320718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs.
    Bourne N; Ireland J; Stanberry LR; Bernstein DI
    Antiviral Res; 1999 Jan; 40(3):139-44. PubMed ID: 10027648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig.
    Landry ML; Lucia HL; Hsiung GD; Pronovost AD; Dann PR; August MJ; Mayo DR
    Am J Med; 1982 Jul; 73(1A):143-50. PubMed ID: 6285705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal herpes simplex virus infection: pathogenesis and treatment in the guinea pig.
    Bravo FJ; Myers MG; Stanberry LR
    J Infect Dis; 1994 May; 169(5):947-55. PubMed ID: 8169425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Bernstein DI; Ireland J; Bourne N
    Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.
    Docherty JJ; Fu MM; Hah JM; Sweet TJ; Faith SA; Booth T
    Antiviral Res; 2005 Sep; 67(3):155-62. PubMed ID: 16125258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.